Adage Capital Partners’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.35M	Buy	+300,000	New	+$1.2M	﹤0.01%	864
2025 Q4	–	Sell	-1,900,000	Closed	-$6.14M	–	966
2025 Q3	$6.14M	Buy	+1,900,000	New	+$7.12M	0.01%	710
2025 Q1	–	Sell	-2,100,000	Closed	-$8.13M	–	903
2024 Q4	$8.13M	Buy	2,100,000 +399,123	+23%	+$2.63M	0.01%	654
2024 Q3	$11.1M	Buy	1,700,877 +329,377	+24%	+$2.65M	0.02%	587
2024 Q2	$9.94M	Sell	1,371,500 -61,953	-4%	-$474K	0.02%	609
2024 Q1	$10.9M	Buy	1,433,453 +156,773	+12%	+$1.22M	0.02%	583
2023 Q4	$5.81M	Buy	1,276,680 +100,000	+8%	+$337K	0.01%	665
2023 Q3	$4.65M	Buy	1,176,680 +525,000	+81%	+$1.99M	0.01%	674
2023 Q2	$2.04M	Hold	651,680	–	–	﹤0.01%	741
2023 Q1	$2.95M	Hold	651,680	–	–	0.01%	749
2022 Q4	$2.69M	Hold	651,680	–	–	0.01%	796
2022 Q3	$2.08M	Buy	651,680 +475,000	+269%	+$1.19M	0.01%	854
2022 Q2	$346K	Hold	176,680	–	–	﹤0.01%	950
2022 Q1	$716K	Hold	176,680	–	–	﹤0.01%	945
2021 Q4	$1.91M	Hold	176,680	–	–	﹤0.01%	873
2021 Q3	$2.04M	Buy	176,680 +100,000	+130%	+$1.2M	﹤0.01%	894
2021 Q2	$753K	Buy	+76,680	New	+$866K	﹤0.01%	919